Stock listing
TSXV:RKV Rakovina Therapeutics Inc Stock
Home listing (TSXV) of Rakovina Therapeutics Inc
Follow Rakovina Therapeutics Inc into a list and get an email when it puts out news.
Share price · TSXV:RKV
$0.175 CAD +0.020 (+12.9%)
Close on Nov 3, 2026
- Day range
- $0.175 – $0.180 CADNov 3, 2026
- Volume
- 3,500 sharesNov 3, 2026
- Market cap
- $4.27M CADAt the close on Nov 3, 2026 · price × 24.41M shares outstanding
- 52-week range
- $0.085 – $0.320 CADLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $4,916 CADMedian day 7,100 shares · 3 days with no trades · last 3 months, Aug 4, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:RKV · Home | $0.175 CAD | +0.020 (+12.9%) | 3,500 | $0.180 | $0.180 | $0.175 | $0.155 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 3, 2026 · TSXV:RKV · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.175 | +0.020 | +12.9% | $0.180 | $0.180 | $0.175 | 3,500 | |
| $0.155 | -0.030 | -16.2% | $0.190 | $0.190 | $0.150 | 14,046 | |
| $0.185 | -0.005 | -2.6% | $0.190 | $0.190 | $0.185 | 1,500 | |
| $0.190 | +0.015 | +8.6% | $0.190 | $0.190 | $0.190 | 6,000 | |
| $0.175 | +0.010 | +6.1% | $0.180 | $0.180 | $0.175 | 2,500 | |
| $0.165 | -0.020 | -10.8% | $0.205 | $0.205 | $0.165 | 5,525 | |
| $0.185 | +0.015 | +8.8% | $0.185 | $0.185 | $0.185 | 500 | |
| $0.170 | +0.010 | +6.3% | $0.175 | $0.175 | $0.170 | 1,522 | |
| $0.160 | -0.025 | -13.5% | $0.200 | $0.200 | $0.160 | 38,102 | |
| $0.185 | -0.040 | -17.8% | $0.225 | $0.225 | $0.185 | 6,501 | |
| $0.225 | +0.005 | +2.3% | $0.200 | $0.225 | $0.200 | 3,060 | |
| $0.220 | 0.000 | 0.0% | $0.220 | $0.220 | $0.220 | 600 | |
| $0.220 | -0.005 | -2.2% | $0.230 | $0.230 | $0.220 | 1,567 | |
| $0.225 | +0.005 | +2.3% | $0.220 | $0.250 | $0.220 | 3,590 | |
| $0.220 | -0.005 | -2.2% | $0.190 | $0.245 | $0.190 | 18,943 | |
| $0.225 | -0.005 | -2.2% | $0.245 | $0.245 | $0.225 | 6,500 | |
| $0.230 | -0.020 | -8.0% | $0.250 | $0.275 | $0.220 | 7,600 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.250 | 507 | |
| $0.250 | -0.020 | -7.4% | $0.250 | $0.250 | $0.250 | 1,272 | |
| $0.270 | 0.000 | 0.0% | $0.270 | $0.270 | $0.270 | 0 | |
| $0.270 | +0.020 | +8.0% | $0.250 | $0.270 | $0.230 | 23,000 | |
| $0.250 | +0.005 | +2.0% | $0.250 | $0.250 | $0.250 | 6,951 | |
| $0.245 | -0.010 | -3.9% | $0.260 | $0.260 | $0.245 | 142,550 | |
| $0.255 | +0.005 | +2.0% | $0.260 | $0.260 | $0.255 | 4,220 | |
| $0.250 | +0.005 | +2.0% | $0.250 | $0.250 | $0.250 | 7,070 | |
| $0.245 | +0.015 | +6.5% | $0.275 | $0.275 | $0.240 | 32,917 | |
| $0.230 | -0.020 | -8.0% | $0.250 | $0.250 | $0.230 | 31,500 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.250 | 4,500 | |
| $0.250 | -0.005 | -2.0% | $0.250 | $0.250 | $0.250 | 21,056 | |
| $0.255 | 0.000 | 0.0% | $0.255 | $0.255 | $0.255 | 1,544 | |
| $0.255 | +0.010 | +4.1% | $0.260 | $0.260 | $0.255 | 2,858 | |
| $0.245 | +0.005 | +2.1% | $0.245 | $0.245 | $0.245 | 500 | |
| $0.240 | -0.025 | -9.4% | $0.230 | $0.240 | $0.230 | 12,500 | |
| $0.265 | +0.015 | +6.0% | $0.285 | $0.285 | $0.250 | 85,034 | |
| $0.250 | +0.040 | +19.0% | $0.220 | $0.250 | $0.220 | 30,500 | |
| $0.210 | -0.005 | -2.3% | $0.205 | $0.220 | $0.190 | 50,111 | |
| $0.215 | -0.045 | -17.3% | $0.265 | $0.265 | $0.215 | 9,710 | |
| $0.260 | -0.060 | -18.8% | $0.260 | $0.260 | $0.260 | 28,566 | |
| $0.320 | +0.100 | +45.5% | $0.220 | $0.320 | $0.220 | 168,944 | |
| $0.220 | 0.000 | 0.0% | $0.220 | $0.220 | $0.220 | 2,000 | |
| $0.220 | 0.000 | 0.0% | $0.220 | $0.220 | $0.220 | 0 | |
| $0.220 | -0.005 | -2.2% | $0.225 | $0.230 | $0.220 | 27,000 | |
| $0.225 | +0.050 | +28.6% | $0.230 | $0.230 | $0.200 | 18,100 | |
| $0.175 | -0.045 | -20.5% | $0.225 | $0.225 | $0.170 | 12,613 | |
| $0.220 | +0.010 | +4.8% | $0.220 | $0.220 | $0.220 | 500 | |
| $0.210 | 0.000 | 0.0% | $0.210 | $0.210 | $0.210 | 12,600 | |
| $0.210 | +0.005 | +2.4% | $0.185 | $0.230 | $0.185 | 74,001 | |
| $0.205 | +0.010 | +5.1% | $0.205 | $0.205 | $0.195 | 32,000 | |
| $0.195 | +0.005 | +2.6% | $0.195 | $0.195 | $0.195 | 2,946 | |
| $0.190 | +0.010 | +5.6% | $0.150 | $0.200 | $0.150 | 3,000 | |
| $0.180 | 0.000 | 0.0% | $0.180 | $0.180 | $0.180 | 0 | |
| $0.180 | -0.010 | -5.3% | $0.200 | $0.200 | $0.180 | 7,100 | |
| $0.190 | +0.020 | +11.8% | $0.180 | $0.190 | $0.180 | 66,500 | |
| $0.170 | +0.020 | +13.3% | $0.150 | $0.170 | $0.150 | 7,208 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.130 | 62,500 | |
| $0.150 | -0.020 | -11.8% | $0.155 | $0.155 | $0.150 | 3,036 | |
| $0.170 | +0.040 | +30.8% | $0.135 | $0.170 | $0.130 | 25,563 | |
| $0.130 | +0.010 | +8.3% | $0.115 | $0.130 | $0.115 | 6,057 | |
| $0.120 | -0.010 | -7.7% | $0.120 | $0.120 | $0.120 | 21,001 | |
| $0.130 | +0.010 | +8.3% | $0.130 | $0.130 | $0.130 | 42,000 | |
| $0.120 | -0.010 | -7.7% | $0.120 | $0.135 | $0.120 | 76,217 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.140 | $0.130 | 86,136 | |
| $0.130 | +0.010 | +8.3% | $0.120 | $0.130 | $0.120 | 105,500 |
- Ticker
- TSXV:RKV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Oct 28, 2026
Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
Latest deck · May 2026
Investor Presentation (May 2026)
Investor deck · 28 slides
Latest news
Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
Oct 28, 2026
Closed $0.19 (+8.6%) on Oct 29, 2026
Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection
Oct 22, 2026
Closed $0.17 (+6.3%) on Oct 22, 2026
Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI
Oct 14, 2026
Closed $0.225 (+2.3%) on Oct 14, 2026
Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development
Oct 1, 2026
Closed $0.25 (+2.0%) on Oct 1, 2026
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
Sep 17, 2026
Closed $0.245 (+2.1%) on Sep 17, 2026
Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
Sep 10, 2026
Closed $0.215 (-17.3%) on Sep 10, 2026
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
Aug 31, 2026
Closed $0.225 (+28.6%) on Sep 1, 2026
Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
Aug 31, 2026
Closed $0.225 (+28.6%) on Sep 1, 2026
Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
Aug 19, 2026
Closed $0.18 (-5.3%) on Aug 19, 2026
Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
Aug 12, 2026
Closed $0.17 (+30.8%) on Aug 12, 2026
Financings
Private placement of units
Aug 31, 2026
Closed: C$1.99M raised · C$0.1 a unit · ½ warrant at C$0.2 for 24 months
Buyers: Kim Oishi (subscribed through First Growth Equity Partners Inc.); David Kideckel
Insiders: Insiders subscribed for 2,120,000 Units across the Offering for $212,000, including 220,000 Units in the Second Tranche for $22,000
Use of proceeds: Advance pipeline: kt-5000AI testing and AI lead optimization, kt-3000 LNP formulation, kt-2000AI development, and general working capital
Announced Jul 15, 2026 · Tranche closed Aug 12, 2026 · Closed Aug 31, 2026
Decks
Investor Presentation (May 2026)
Investor deck · 28 slides · May 2026
Investor Presentation (February 2026)
Investor deck · 25 slides · February 2026
Investor Presentation (November 2025)
Investor deck · 20 slides · November 2025
Investor Presentation (July 2025)
Investor deck · 19 slides · July 2025
Rakovina Therapeutics Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 83 in all · newest Oct 28, 2026 · oldest 2021
- Decks
- 14 decks · latest May 2026
Where Rakovina Therapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:RKV · Home listing · This page | TSXV | Canada | CAD |
| Cboe Canada:RKV | Cboe Canada | Canada | CAD |
| LS Exchange:A41APT | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41APT | Lang & Schwarz | Germany | EUR |
| OTC:RKVTF | OTC | United States | USD |
| Stuttgart:7JO0 | Stuttgart | Germany | EUR |
| Frankfurt:7JO0 | Frankfurt | Germany | EUR |
| gettex:7JO0 | gettex | Germany | EUR |
| Munich:7JO0 | Munich | Germany | EUR |
| Tradegate:7JO0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Rakovina Therapeutics Inc.